Société Lantheus Holdings, Inc.
Actions
LNTH
US5165441032
Equipement, fournitures et distribution médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
75,53 USD | -3,39% | +15,21% | +21,82% |
Métier
Nombre d'employés: 834
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
PYLARIFY
65,7
%
| 527 | 56,4 % | 851 | 65,7 % | +61,41% |
DEFINITY
21,6
%
| 245 | 26,2 % | 280 | 21,6 % | +14,19% |
TechneLite
6,7
%
| 89 | 9,5 % | 87 | 6,7 % | -1,68% |
Strategic Partnerships and Other
4,0
%
| 47 | 5,0 % | 52 | 4,0 % | +10,68% |
Other Precision Diagnostics
1,8
%
| 23 | 2,4 % | 23 | 1,8 % | +0,68% |
Other Radiopharmaceutical Oncology
0,2
%
| 4 | 0,4 % | 3 | 0,2 % | -23,70% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
97,4
%
| 901 | 96,4 % | 1 263 | 97,4 % | +40,08% |
International
2,6
%
| 34 | 3,6 % | 34 | 2,6 % | +0,13% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Brian Markison
CEO | Chief Executive Officer | 64 | 01/09/12 |
Paul Blanchfield
PSD | President | 43 | 27/01/20 |
Robert Marshall
DFI | Director of Finance/CFO | 57 | 21/09/18 |
Mary Heino
CHM | Chairman | 64 | 01/04/13 |
Iryna Teslenko
CTO | Chief Tech/Sci/R&D Officer | - | 07/04/21 |
Bela Denes
CTO | Chief Tech/Sci/R&D Officer | - | 07/04/21 |
Chief Tech/Sci/R&D Officer | 60 | 04/04/22 | |
Chief Administrative Officer | 47 | 01/09/13 | |
Mark Kinarney
IRC | Investor Relations Contact | - | 01/01/18 |
Linda S. Lennox
IRO | Public Communications Contact | 59 | 01/08/20 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Brian Markison
CEO | Chief Executive Officer | 64 | 01/09/12 |
James H. Thrall
BRD | Director/Board Member | 80 | 01/02/18 |
Sam Leno
BRD | Director/Board Member | 78 | 01/05/12 |
Mary Heino
CHM | Chairman | 64 | 01/04/13 |
Gary Pruden
BRD | Director/Board Member | 62 | 01/02/18 |
Julie McHugh
BRD | Director/Board Member | 59 | 01/01/17 |
Director/Board Member | 76 | 01/02/22 | |
Gérard Ber
BRD | Director/Board Member | 66 | 19/06/20 |
Director/Board Member | 61 | 19/06/20 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 70 651 588 | 66 792 876 ( 94,54 %) | 1 339 000 ( 1,895 %) | 94,54 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
116 773 394 | 19,90% | 138 960 339 $ |
Coordonnées société
Lantheus Holdings, Inc.
201 Burlington Road South Building
01730, Bedford
+978 671 8001
http://www.lantheus.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Lantheus Medical Imaging, Inc.
Lantheus Medical Imaging, Inc. Medical SpecialtiesHealth Technology Lantheus Medical Imaging, Inc. engages in the manufacture, marketing, sale, and distribution of medical imaging products. It provides diagnostic imaging and nuclear medicine products that assist clinicians with the detection of disease, primarily cardiovascular. Its product protfolio includes DEFINITY, TechneLite, Xenon, AZEDRA, Cardiolite, and NEUROLITE. The company was founded in 1956 and is headquartered in North Billerica, MA. |
Medical Specialties
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+21,82% | 5,24 Md | |
-1,89% | 12,56 Md | |
-9,59% | 7,68 Md | |
-1,31% | 5,29 Md | |
+0,02% | 4,57 Md | |
-50,89% | 3,29 Md | |
+6,42% | 2,6 Md | |
-10,02% | 2,2 Md | |
-8,29% | 1,79 Md | |
+1,72% | 1,76 Md |
- Bourse
- Actions
- Action LNTH
- Société Lantheus Holdings, Inc.